Royal Bank Of Canada Day One Biopharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

$458 Billion
Q1 2025

A detailed history of Royal Bank Of Canada transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 185,733 shares of DAWN stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

185,733

Previous 132,274 40.42%

Holding current value

$1.17 Million

Previous $1.68 Million 12.12%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$7.93 - $13.21 $423,929 - $706,193	53,459 Added 40.42%	185,733 $1.47 Million
Q4 2024 Feb 14, 2025	BUY	$12.46 - $16.39 $1.19 Million - $1.57 Million	95,625 Added 260.92%	132,274 $1.68 Million
Q3 2024 Nov 14, 2024	BUY	$12.72 - $16.03 $375,672 - $473,430	29,534 Added 415.09%	36,649 $510,000
Q2 2024 Aug 14, 2024	BUY	$12.03 - $17.69 $41,010 - $60,305	3,409 Added 91.99%	7,115 $98,000
Q1 2024 Nov 05, 2024	SELL	$13.56 - $17.46 $46,226 - $59,521	-3,409 Reduced 47.91%	3,706 $61,000
Q1 2024 May 15, 2024	SELL	$13.56 - $17.46 $237,489 - $305,794	-17,514 Reduced 82.54%	3,706 $61,000
Q4 2023 Feb 14, 2024	BUY	$9.68 - $15.37 $111,310 - $176,739	11,499 Added 118.29%	21,220 $309,000
Q3 2023 Nov 14, 2023	BUY	$11.22 - $14.86 $54,304 - $71,922	4,840 Added 99.16%	9,721 $119,000
Q2 2023 Aug 14, 2023	BUY	$11.74 - $14.47 $24,383 - $30,054	2,077 Added 74.07%	4,881 $58,000
Q1 2023 May 15, 2023	SELL	$12.75 - $23.41 $19,571 - $35,934	-1,535 Reduced 35.38%	2,804 $37,000
Q4 2022 Feb 14, 2023	BUY	$18.77 - $22.0 $53,156 - $62,304	2,832 Added 187.92%	4,339 $93,000
Q3 2022 Nov 14, 2022	BUY	$16.44 - $26.57 $3,797 - $6,137	231 Added 18.1%	1,507 $30,000
Q2 2022 Aug 15, 2022	SELL	$5.72 - $17.9 $7,241 - $22,661	-1,266 Reduced 49.8%	1,276 $22,000
Q1 2022 May 16, 2022	SELL	$9.12 - $17.47 $6,958 - $13,329	-763 Reduced 23.09%	2,542 $25,000
Q4 2021 Feb 14, 2022	BUY	$15.65 - $26.33 $30,188 - $50,790	1,929 Added 140.19%	3,305 $55,000
Q3 2021 Nov 15, 2021	BUY	$20.0 - $27.92 $27,520 - $38,417	1,376 New	1,376 $33,000

Others Institutions Holding DAWN

# of Institutions

196

Shares Held

76.7M

Call Options Held

138K

Put Options Held

208K

View Full List

About Day One Biopharmaceuticals, Inc.

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $462M
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

More about DAWN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Day One Biopharmaceuticals, Inc. Transaction History